REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,948,599 | -19.8% | 847,424 | -2.6% | 12.64% | +31.1% |
Q2 2023 | $17,393,579 | +10.7% | 870,114 | +4.7% | 9.64% | +48.0% |
Q1 2023 | $15,714,475 | -22.8% | 831,014 | -7.4% | 6.51% | -14.8% |
Q4 2022 | $20,359,473 | -20.4% | 897,684 | -7.2% | 7.65% | -17.0% |
Q3 2022 | $25,576,000 | -11.3% | 967,684 | -17.1% | 9.22% | -6.3% |
Q2 2022 | $28,842,000 | -22.3% | 1,167,684 | +4.4% | 9.84% | +80.4% |
Q1 2022 | $37,129,000 | +12.0% | 1,118,684 | +10.4% | 5.46% | +45.2% |
Q4 2021 | $33,145,000 | -5.8% | 1,013,596 | +20.8% | 3.76% | -41.2% |
Q3 2021 | $35,177,000 | +52.1% | 839,139 | +40.9% | 6.39% | +6.3% |
Q2 2021 | $23,133,000 | +21.2% | 595,444 | +6.4% | 6.01% | +74.3% |
Q1 2021 | $19,083,000 | -16.4% | 559,444 | +11.1% | 3.45% | -27.3% |
Q4 2020 | $22,836,000 | +62.5% | 503,444 | -1.4% | 4.75% | +219.0% |
Q3 2020 | $14,056,000 | -31.0% | 510,760 | -7.7% | 1.49% | -63.8% |
Q2 2020 | $20,384,000 | +130.4% | 553,453 | +102.6% | 4.11% | +19.2% |
Q1 2020 | $8,847,000 | -19.7% | 273,211 | +1.6% | 3.45% | -16.6% |
Q4 2019 | $11,012,000 | – | 268,778 | – | 4.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |